Lucerón-Lucas-Torres Maribel, Cavero-Redondo Iván, Martínez-Vizcaíno Vicente, Bizzozero-Peroni Bruno, Pascual-Morena Carlos, Álvarez-Bueno Celia
Health and Social Research Center, Universidad de Castilla-La Mancha, Cuenca, Spain.
Facultad de Ciencias de la Salud, Universidad Autónoma de Chile, Talca, Chile.
Front Nutr. 2023 Sep 4;10:1197745. doi: 10.3389/fnut.2023.1197745. eCollection 2023.
Alcohol consumption is related to the risk of developing different types of cancer. However, unlike other alcoholic beverages, moderate wine drinking has demonstrated a protective effect on the risk of developing several types of cancer.
To analyze the association between wine consumption and the risk of developing cancer.
We searched the MEDLINE (through PubMed), Scopus, Cochrane, and Web of Science databases to conduct this systematic review and meta-analysis. Pooled relative risks (RRs) were calculated using the DerSimonian and Laird methods. I2 was used to evaluate inconsistency, the τ2 test was used to assess heterogeneity, and The Newcastle-Ottawa Quality Assessment Scale were applied to evaluate the risk of bias. This study was previously registered in PROSPERO, with the registration number CRD42022315864.
Seventy-three studies were included in the systematic review, and 26 were included in the meta-analysis. The pooled RR for the effect of wine consumption on the risk of gynecological cancers was 1.03 (95% CI: 0.99, 1.08), that for colorectal cancer was 0.92 (95% CI: 0.82, 1.03), and that for renal cancer was 0.92 (95% CI: 0.81, 1.04). In general, the heterogeneity was substantial.
The study findings reveal no association between wine consumption and the risk of developing any type of cancer. Moreover, wine drinking demonstrated a protective trend regarding the risk of developing pancreatic, skin, lung, and brain cancer as well as cancer in general.
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022315864, identifier CRD42022315864 (PROSPERO).
饮酒与患不同类型癌症的风险相关。然而,与其他酒精饮料不同,适度饮用葡萄酒对多种癌症的发生风险具有保护作用。
分析饮用葡萄酒与患癌风险之间的关联。
我们检索了MEDLINE(通过PubMed)、Scopus、Cochrane和科学网数据库来进行这项系统评价和荟萃分析。采用DerSimonian和Laird方法计算合并相对风险(RR)。I²用于评估不一致性,τ²检验用于评估异质性,并应用纽卡斯尔-渥太华质量评估量表评估偏倚风险。本研究先前已在PROSPERO注册,注册号为CRD42022315864。
系统评价纳入了73项研究,荟萃分析纳入了26项研究。饮用葡萄酒对妇科癌症风险影响的合并RR为1.03(95%CI:0.99,1.08),对结直肠癌的合并RR为0.92(95%CI:0.82,1.03),对肾癌的合并RR为0.92(95%CI:0.81,1.04)。总体而言,异质性较大。
研究结果显示饮用葡萄酒与患任何类型癌症的风险之间无关联。此外,饮用葡萄酒在胰腺癌、皮肤癌、肺癌和脑癌以及总体癌症风险方面呈现出保护趋势。
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022315864,标识符CRD42022315864(PROSPERO)